Evaluation of the roles of common genetic mutations in leukoaraiosis

Objectives– Leukoaraiosis, a relatively frequent neuroimaging entity, is presumed to be primarily a vascular problem. However, it can be explained only in part by vascular risk factors. With the assumption of genetic susceptibility, the roles of common genetic polymorphisms and mutations in leukoaraiosis were examined in this study. Material and methods– A detailed clinical scrutiny of 843 Hungarian neurological patients with mild cognitive‐like complaints revealed 229 subjects with leukoaraiosis that was probably vascular in origin: 143 with leukoaraiosis alone (group 1), and 86 with leukoaraiosis plus cerebral infarction (group 2). In all 229 patients, the methylenetetrahydrofolate reductase C677T (MTHFR C677T) mutation and angiotensin‐converting enzyme (ACE I/D) polymorphism were examined by means of the PCR technique. The prevalences of the different genotypes for the examined mutations in the 2 groups were analysed in comparison with the data on 362 neuroimaging alteration‐free subjects as controls. Results– The ACE D/D genotype (38.37%, P<0.0005; OR 2.46, 95% CI, 1.49–4.08) and ACE D allele (61%; P<0.001) were more frequent in group 2 than in the control group (20.17%; 47%). Neither the homozygous nor the heterozygous MTHFR C677T mutation alone was found to be a risk factor for leukoaraiosis. The homozygous MTHFR C677T mutation combined with the ACE D/D genotype was significantly more frequent in group 1 (11.89%, P<0.0005; OR 4.75, 95% CI, 2.12–10.65), in group 2 (12.79%, P<0.0005; OR 5.16, 95% CI, 2.12–12.6) and in combined group 1+2 (12.23%, P<0.0005; OR 4.9, 95% CI, 2.33–10.3) than in the control group (2.76%). Conclusion– These data indicate that the contributions of the ACE D/D genotype and the homozygous MTHFR C677T mutation to leukoaraiosis should be taken into consideration not as major, but as additive factors. These findings draw attention to the fact that genetic polymorphisms that alone are insignificant can be risk factors for leukoaraiosis if they cluster in the same subjects.

[1]  E. Falk,et al.  Homocysteine and atherothrombosis , 2001, Lipids.

[2]  J. van Gijn,et al.  Leukoaraiosis and vascular dementia , 1998, Neurology.

[3]  K. Shimada,et al.  Diurnal blood pressure variations and silent cerebrovascular damage in elderly patients with hypertension. , 1992, Journal of hypertension.

[4]  David Lee Gordon,et al.  Classification of Subtype of Acute Ischemic Stroke: Definitions for Use in a Multicenter Clinical Trial , 1993, Stroke.

[5]  F. Fazekas,et al.  Angiotensinogen Gene Promoter Haplotype and Microangiopathy-Related Cerebral Damage: Results of the Austrian Stroke Prevention Study , 2001, Stroke.

[6]  M. Owen,et al.  Variation in DCP1, encoding ACE, is associated with susceptibility to Alzheimer disease , 1999, Nature Genetics.

[7]  I. Perry.  Homocysteine, hypertension and stroke , 1999, Journal of Human Hypertension.

[8]  W. Smith,et al.  Subcortical arteriosclerotic encephalopathy (Binswanger's type) and cortical infarcts in a young normotensive patient. , 1982, Journal of neurology, neurosurgery, and psychiatry.

[9]  B. Miller,et al.  A quantitative MRI study of vascular dementia , 1992, Neurology.

[10]  A. Brun,et al.  A white matter disorder in dementia of the Alzheimer type: A pathoanatomical study , 1986, Annals of neurology.

[11]  H. Markus,et al.  Angiotensin-converting enzyme gene deletion polymorphism. A new risk factor for lacunar stroke but not carotid atheroma. , 1995, Stroke.

[12]  H. Tohgi,et al.  Twenty-four-hour variation of blood pressure in vascular dementia of the Binswanger type. , 1991, Stroke.

[13]  J. Wade,et al.  Vascular risk factors and leuko-araiosis. , 1987, Archives of neurology.

[14]  J. Marshall,et al.  Hypoperfusion in the aetiology of subcortical arteriosclerotic encephalopathy (Binswanger type) , 1984, Journal of neurology, neurosurgery, and psychiatry.

[15]  F. Soubrier,et al.  PCR detection of the insertion/deletion polymorphism of the human angiotensin converting enzyme gene (DCP1) (dipeptidyl carboxypeptidase 1). , 1992, Nucleic acids research.

[16]  A Capdevila,et al.  Leuko-araiosis on magnetic resonance imaging and speed of mental processing. , 1990, Archives of neurology.

[17]  C. Lavie,et al.  Renin-angiotensin system: genes to bedside. , 1997, American heart journal.

[18]  Shirley A. Miller,et al.  A simple salting out procedure for extracting DNA from human nucleated cells. , 1988, Nucleic acids research.

[19]  M. Zaudig,et al.  A New Systematic Method of Measurement and Diagnosis of “Mild Cognitive Impairment” and Dementia According to ICD-10 and DSM-III-R Criteria , 1992, International Psychogeriatrics.

[20]  R. D'Agostino,et al.  Nonfasting Plasma Total Homocysteine Levels and Stroke Incidence in Elderly Persons: The Framingham Study , 1999, Annals of Internal Medicine.

[21]  M. Daemen,et al.  Angiotensin II induces smooth muscle cell proliferation in the normal and injured rat arterial wall. , 1991, Circulation research.

[22]  D. O'leary,et al.  White matter lucencies on computed tomography, subacute arteriosclerotic encephalopathy (Binswanger's disease), and blood pressure. , 1987, Stroke.

[23]  J. Garcìa,et al.  Pathogenesis of leukoaraiosis: a review. , 1997, Stroke.

[24]  C. Frost,et al.  Leukoaraiosis at Presentation and Disease Progression during Follow‐up in Histologically Confirmed Cases of Dementia , 2000, Annals of the New York Academy of Sciences.

[25]  H. Kawakami,et al.  Cerebral white matter lesions are not associated with apoE genotype but with age and female sex in Alzheimer's disease , 2000, Journal of neurology, neurosurgery, and psychiatry.

[26]  T. Erkinjuntti,et al.  White matter changes in healthy elderly persons correlate with attention and speed of mental processing. , 1993, Archives of neurology.

[27]  M. Szabó,et al.  Common Genetic Mutations as Possible Aetiological Factors in Stroke , 2001, European Neurology.

[28]  岩本俊彦.  Leuko-araiosis と血管性痴呆 , 1996 .

[29]  K. Matsushita,et al.  Periventricular white matter lucency and cerebral blood flow autoregulation in hypertensive patients. , 1994, Hypertension.

[30]  E. Ringelstein,et al.  Features, symptoms, and neurophysiological findings in stroke associated with hyperhomocysteinemia. , 1997, Archives of neurology.

[31]  X. Wang.  A theory for the mechanism of homocysteine-induced vascular pathogenesis. , 1999, Medical hypotheses.

[32]  H. Markus,et al.  Genetics and ischaemic stroke. , 2000, Brain : a journal of neurology.

[33]  S. Ibayashi,et al.  Polymorphism of the angiotensin-converting enzyme (ACE) gene in patients with thrombotic brain infarction. , 1997, Atherosclerosis.

[34]  P. Touboul,et al.  Plasma angiotensin-converting enzyme activity and carotid wall thickening. , 1994, Circulation.

[35]  J. Bogousslavsky,et al.  What is the significance of leukoaraiosis in patients with acute ischemic stroke? , 2000, Archives of neurology.

[36]  A. Kitamura,et al.  Plasma Level of Homocysteine is Correlated to Extracranial Carotid-Artery Atherosclerosis in Non-Hypertensive Japanese , 1999, Journal of cardiovascular risk.

[37]  H. Ishino,et al.  An Autopsy Case of Binswanger's Disease without Hypertension and Associated with Cerebral Infarction in the Terminal Stage , 1993, The Japanese journal of psychiatry and neurology.

[38]  F. Fazekas,et al.  Apolipoprotein E polymorphism and silent microangiopathy-related cerebral damage. Results of the Austrian Stroke Prevention Study. , 1997, Stroke.

[39]  V. Hachinski,et al.  Cognitive and neurologic findings in demented patients with diffuse white matter lucencies on computed tomographic scan (leuko-araiosis). , 1987, Archives of neurology.

[40]  H Merskey,et al.  Leuko-Araiosis: An Ancient Term for a New Problem , 1986, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[41]  G. Wilcock,et al.  Are genetic factors important in the aetiology of leukoaraiosis? Results from a memory clinic population , 1998, International journal of geriatric psychiatry.

[42]  A. Alavi,et al.  MR signal abnormalities at 1.5 T in Alzheimer's dementia and normal aging. , 1987, AJR. American journal of roentgenology.

[43]  I. Mcdowell,et al.  Genotyping method for methylenetetrahydrofolate reductase (C677T thermolabile variant) using heteroduplex technology. , 1998, Clinical chemistry.

[44]  J. Gijn.  Leukoaraiosis and vascular dementia , 1998 .

[45]  F. Fazekas,et al.  Pathologic correlates of incidental MRI white matter signal hyperintensities , 1993, Neurology.

[46]  M. Szabó,et al.  A clustering of unfavourable common genetic mutations in stroke cases , 2000, Acta neurologica Scandinavica.

[47]  D. Inzitari,et al.  Vascular Risk Factors Linked to Multiple Lacunar Infarcts , 1998, Cerebrovascular Diseases.

[48]  C. Oppenheim,et al.  [Vascular pathology]. , 2002, Presse medicale.

[49]  L. Bortolotto,et al.  Plasma homocysteine, aortic stiffness, and renal function in hypertensive patients. , 1999, Hypertension.

[50]  Y. Tseng,et al.  Determination of angiotensin-converting enzyme gene polymorphisms: stepdown PCR increases detection of heterozygotes. , 1998, Clinical chemistry.

[51]  V. Hachinski,et al.  Cognitive and neurologic findings in subjects with diffuse white matter lucencies on computed tomographic scan (leuko-araiosis). , 1987, Archives of neurology.

[52]  J. Pruvo,et al.  Risk factors and leukoaraiosis in stroke patients , 1996, Acta neurologica Scandinavica.

[53]  F. Fazekas,et al.  MRI cerebral white matter lesions and paraoxonase PON1 polymorphisms : three-year follow-up of the austrian stroke prevention study. , 2000, Arteriosclerosis, thrombosis, and vascular biology.